Financials
Financial year 2025
APOTHEEK KACHTEM from Izegem, company number BE0632575404, closed financial year 2025 with a result of € 73,884 after tax. For that financial year APOTHEEK KACHTEM recorded a gross margin of € 116,213 and equity of € 113,775. Compared with financial year 2024, the result moved from € 722 to € 73,884. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 17, 2026.
€ 113,775
▲ 185% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 73,884
▲ € 73,161 vs 2024
Profit after tax over the fiscal year.
€ 21,402
▼ 59% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 107,558.
People and assets in 2025
≈ 1
No payroll staff. One director, so that person most likely runs the business.
Debts at end 2025
€ 7,560
▼ 92% vs 2024
Loans from banks and other lenders, long and short.
€ 5,836
▲ 4% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 89,741 | € 94,918 | € 94,632 | € 116,213 | ▲ 23% |
| Profit after taxes | € -6,198 | € 1,443 | € 722 | € 73,884 | ▲ € 73,161 |
| Equity | € 37,726 | € 39,169 | € 39,891 | € 113,775 | ▲ 185% |
| Total debts | € 285,093 | € 194,503 | € 104,062 | € 13,395 | ▼ 87% |
| Cash | € 41,639 | € 52,182 | € 51,894 | € 21,402 | ▼ 59% |
| Retained profit | € 31,509 | € 32,952 | € 33,675 | € 107,558 | ▲ 219% |
| Bank debt | € 279,667 | € 188,965 | € 98,262 | € 7,560 | ▼ 92% |
| Balance sheet total | € 322,819 | € 233,672 | € 143,954 | € 127,170 | ▼ 12% |
Key figures of APOTHEEK KACHTEM, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to APOTHEEK KACHTEM?
What happened at APOTHEEK KACHTEM in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 73,884 (▲ € 73,161 vs 2024). Source: NBB ↗
- New establishment in Izegem. KBO
- Start of the company according to the CBE. KBO
In short
From € 6,198 loss in 2022 to € 73,884 profit in 2025.
Paid € 5,322 in corporate taxes since 2022.
Best year ever: 2025, with € 73,884 profit.
Management
Behind APOTHEEK KACHTEM are Delbeke-Aerts BV and Wim Degezelle. Delbeke-Aerts BV is also behind UNIDOSE PHARMA, APOTHEEK DELBEKE - AERTS and IMDELAER. Wim Degezelle is also behind PAPERASSI and RHODESGOED.
Directors
According to the 2025 annual accounts
Director · represented by Matthias Delbeke
Also active at: UNIDOSE PHARMA, APOTHEEK DELBEKE - AERTS, IMDELAER
Establishments
Establishment units
Physical locations of this company
Rhodesstraat 2
8870 Izegem
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 5 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0632.575.404
- VAT number
- BE 0632.575.404
- Registered office
- Rhodesstraat 2, 8870 Izegem
- Names & denominations
- APOTHEEK KACHTEM
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 18 June 2015
- Peppol
- Active · Active since 21 Oct 2026
- Activities · NACE
Activiteiten van holdings
Holdings
Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies
Overige zakelijke dienstverlening, neg
Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering